GoAI
Get started
Yestar Healthcare Holdings Company Limited logo

Yestar Healthcare Holdings Company Limited

2393.HK

HKSEHealthcareMedical - Distribution

Open in GoAI

Latest quote

HK$0.056

−HK$0.001 · -1.75%

Aug 20, 11:18 AM HKTData delayed

2393.HK company overview

Historical prices · Market data may be delayed.

Company profile

Company website

Yestar Healthcare Holdings Company Limited, an investment holding company, manufactures, distributes, and sells medical imaging products in Mainland China. The company operates in two segments, Imaging Printing Products, and Medical Products and Equipment. The Imaging Printing Products segment manufactures and sells color photographic paper and industrial NDT x-ray films and PWB films, as well as trades in imaging equipment. The Medical Products and Equipment segment manufactures and sells medical dry, medical wet, and dental films, as well as sells medical equipment and diagnostic reagents. The company also engages in the management of supply chain and service of freight transportation equipment, as well as development of biotechnology. The company was formerly known as Yestar International Holdings Company Limited and changed its name to Yestar Healthcare Holdings Company Limited in January 2017. Yestar Healthcare Holdings Company Limited was founded in 1971 and is headquartered in Shanghai, the People’s Republic of China.

Industry
Medical - Distribution
Sector
Healthcare
Headquarters
CN
CEO
Chun Lai Wang
Listed since
Oct 11, 2013
Employees
448

Market position

52-week range

Current HK$0.056

Open
HK$0.056
Previous close
HK$0.057
Volume
60K
0.11× average
Average volume
524.08K
Average daily volume
Market cap
130.57M HKD
Beta
-0.04
Market reference 1
50-day average
HK$0.0602
-7.04% below average
200-day average
HK$0.0918
-38.97% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
188.07M CNY
P/E (TTM)
-1.49×
P/B (TTM)
0.3×
P/S (TTM)
0.08×
EV / EBITDA
5×
Earnings yield
-35.47%
Free cash flow yield
136.82%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
17.91%
Operating margin
0.05%
Net margin
-5.04%
Return on equity
-19.84%
Return on assets
-6.28%
Return on invested capital
0.11%

Financial health

Debt / equity
0.56×
Current ratio
1.37×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends46%16%-13%-43%Gross margin, FY2021: 17.21%Gross margin, FY2022: 14.18%Gross margin, FY2023: 17.60%Gross margin, FY2024: 16.56%Gross margin, FY2025: 17.91%Operating margin, FY2021: 3.71%Operating margin, FY2022: -4.56%Operating margin, FY2023: 4.93%Operating margin, FY2024: -6.38%Operating margin, FY2025: 0.05%Net margin, FY2021: 0.07%Net margin, FY2022: -35.38%Net margin, FY2023: -0.48%Net margin, FY2024: 38.24%Net margin, FY2025: -5.04%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 17.21%. Gross margin FY2022 14.18%. Gross margin FY2023 17.60%. Gross margin FY2024 16.56%. Gross margin FY2025 17.91%. Operating margin FY2021 3.71%. Operating margin FY2022 -4.56%. Operating margin FY2023 4.93%. Operating margin FY2024 -6.38%. Operating margin FY2025 0.05%. Net margin FY2021 0.07%. Net margin FY2022 -35.38%. Net margin FY2023 -0.48%. Net margin FY2024 38.24%. Net margin FY2025 -5.04%.

Income trends

Revenue

1.49B CNY-38.17%

Operating income

771K CNY+154.43M CNY

Net income

−75.03M CNY−996.64M CNY
Income trends across reported periods5.52B CNY3.15B CNY784.65M CNY−1.58B CNYRevenue, FY2021: 4.93B CNYRevenue, FY2022: 2.8B CNYRevenue, FY2023: 2.91B CNYRevenue, FY2024: 2.41B CNYRevenue, FY2025: 1.49B CNYOperating income, FY2021: 183.12M CNYOperating income, FY2022: −127.98M CNYOperating income, FY2023: 143.59M CNYOperating income, FY2024: −153.66M CNYOperating income, FY2025: 771K CNYNet income, FY2021: 3.33M CNYNet income, FY2022: −992.23M CNYNet income, FY2023: −13.89M CNYNet income, FY2024: 921.61M CNYNet income, FY2025: −75.03M CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 4.93B CNY. Revenue FY2022 2.8B CNY. Revenue FY2023 2.91B CNY. Revenue FY2024 2.41B CNY. Revenue FY2025 1.49B CNY. Operating income FY2021 183.12M CNY. Operating income FY2022 −127.98M CNY. Operating income FY2023 143.59M CNY. Operating income FY2024 −153.66M CNY. Operating income FY2025 771K CNY. Net income FY2021 3.33M CNY. Net income FY2022 −992.23M CNY. Net income FY2023 −13.89M CNY. Net income FY2024 921.61M CNY. Net income FY2025 −75.03M CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue1.49B CNY2.41B CNY2.91B CNY2.8B CNY4.93B CNY
Cost of goods sold1.22B CNY2.01B CNY2.4B CNY3.59B CNY4.08B CNY
Gross profit266.86M CNY399.2M CNY512.78M CNY397.55M CNY848.7M CNY
Research and development11.44M CNY33.8M CNY—21.15M CNY1.24M CNY
Selling, general, and administrative238.26M CNY362.41M CNY380.58M CNY364.9M CNY657.01M CNY
Operating expenses266.09M CNY372.37M CNY369.19M CNY525.53M CNY665.57M CNY
Interest income1.13M CNY1.49M CNY2.39M CNY4.96M CNY8.25M CNY
Interest expense10.92M CNY30.16M CNY164.71M CNY273.14M CNY127.79M CNY
Depreciation and amortization25.43M CNY67.93M CNY171.06M CNY230.78M CNY131.52M CNY
Operating income771K CNY−153.66M CNY143.59M CNY−127.98M CNY183.12M CNY
Net income−75.03M CNY921.61M CNY−13.89M CNY−992.23M CNY3.33M CNY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
0%
0 beats, 3 misses, 0 met estimates
Average EPS surprise
-94.38%
3 comparable reports
Latest EPS result
-0.04

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.580.23-0.12-0.47Q3 '22Q1 '23Q3 '23Q1 '24Q3 '24Q1 '25Q3 '25Q1 '26
Q3 2022, reported Aug 24, 2022: actual -0.083, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 31, 2023: actual -0.399, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 25, 2023: actual 0.002, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 27, 2024: actual -0.005, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 29, 2024: actual 0.505, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 28, 2025: actual -0.076, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 29, 2025: actual 0.003, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 27, 2026: actual -0.038, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates5.71B4.02B2.34B650.02MQ3 '22No estimateQ1 '23MissQ3 '23MissQ1 '24MissQ3 '24MissQ1 '25No estimateQ3 '25No estimateQ1 '26No estimate
Q3 2022, reported Aug 24, 2022: actual 2.3B HKD, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 31, 2023: actual 2.65B HKD, estimate 5.1B HKD, surprise -47.97%, Miss. Q3 2023, reported Aug 25, 2023: actual 2.55B HKD, estimate 5.34B HKD, surprise -52.21%, Miss. Q1 2024, reported Mar 27, 2024: actual 1.59B HKD, estimate 5.33B HKD, surprise -70.10%, Miss. Q3 2024, reported Aug 29, 2024: actual 1.37B HKD, estimate 5.09B HKD, surprise -73.13%, Miss. Q1 2025, reported Mar 28, 2025: actual 1.21B HKD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 29, 2025: actual 878.16M HKD, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 27, 2026: actual 764.73M HKD, estimate —, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.055

2018 complete year+147.2% since 2014

Corporate action history

Dividend

Ex-dividend Jun 5, 2018

HK$0.055

Annual

Record Jun 6, 2018 · Payment Jul 5, 2018

Dividend

Ex-dividend Jun 6, 2017

HK$0.044

Annual

Record Jun 7, 2017 · Payment Jul 5, 2017

Dividend

Ex-dividend Jun 3, 2016

HK$0.039

Annual

Record Jun 6, 2016 · Payment Jul 5, 2016

Dividend

Ex-dividend May 20, 2015

HK$0.034

Annual

Record May 21, 2015 · Payment Jun 5, 2015

Dividend

Ex-dividend May 21, 2014

HK$0.089

Annual

Record May 22, 2014 · Payment Jun 6, 2014

2393.HK peers

WuXi AppTec Co., Ltd. logo

2359.HK

WuXi AppTec Co., Ltd.

HK$195.4

-5.05%

Jiangsu Hengrui Pharmaceuticals Co.,Ltd logo

1276.HK

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

HK$46.50

-3.53%

BeOne Medicines AG logo

6160.HK

BeOne Medicines AG

HK$220.2

-3.42%

WuXi Biologics (Cayman) Inc. logo

2269.HK

WuXi Biologics (Cayman) Inc.

HK$48.30

-5.29%

Hansoh Pharmaceutical Group Company Limited logo

3692.HK

Hansoh Pharmaceutical Group Company Limited

HK$31.06

-6.11%

Innovent Biologics, Inc. logo

1801.HK

Innovent Biologics, Inc.

HK$98.90

-3.42%

Continue in GoAI

Research 2393.HK

research.disclaimer